Skip to main content
War in Gaza:: find out how we're responding
Learn more
231 Results For "pneumonia"
 
Nigeria

Malnutrition is the biggest problem in Bama

Interview with MSF project coordinator Hakim Khaldi Voices from the Field - 7 Sep 2016
 
India

MSF calls for affordable pneumonia vaccines ahead of Pfizer’s patent hearing in India

“The pneumonia vaccine is the world’s best-selling vaccine, and last year alone, Pfizer brought in more than US$6 billion dollars in sales just for this product - meanwhile many developing countries, where millions of children risk getting pneumonia, simply can’t afford it”, said Dr Greg Elder, Medical Coordinator for MSF’s Access Campaign. “To make sure children everywhere can be protected from deadly pneumonia, other companies need to be allowed to enter the market so they can supply this vaccine for a much lower price than Pfizer charges.” Press Release - 28 Jul 2016
 
Ethiopia

Two years of drought followed by floods challenge the pastoral way of life

The eastern Ethiopian regions of Afar and Sitti are dry and inhospitable places for much of the year. Yet this is where many pastoralists live, moving from place to place, searching for water and pasture to feed their precious livestock. Project Update - 27 Jun 2016
 
A Fair Shot 1 million pneumonia deaths infographic
Access to medicines

2,500 flowers are placed in front of Pfizer’s HQ, representing number of children who die of pneumonia each day.

“We’ve seen too many children die of pneumonia, and we’re not going to stop until we know that all countries can afford this life-saving vaccine,” Press Release - 27 Apr 2016
 
multi-antigenes vaccination campaign in CAR
Central African Republic

More than 73,000 children vaccinated in an unprecedented campaign

Our head of mission in the Central African Republic talks about MSF's unprecedented vaccination campaign Voices from the Field - 29 Mar 2016
 
PCV Vaccination Campaign in Yida Camp
Access to medicines

MSF launches challenge to Pfizer’s patent on the pneumonia vaccine in India to increase access to more affordable versions

MSF has filed a ‘patent opposition’ in India to prevent US pharmaceutical company Pfizer from getting a patent on the pneumococcal conjugate vaccine (PCV13), so more affordable versions can become available to developing countries and humanitarian organisations. “Pneumonia kills a child every 35 seconds,” says Dr. Manica Balasegaram. “As doctors who have watched far too many children die of pneumonia, we’re not going to back down until we know that all countries can afford this vaccine.” Crisis Update - 11 Mar 2016
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more